Amoxicillin Oral Suspension - British Pharmacopoeia

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

2/9/2021 Amoxicillin Oral Suspension - British Pharmacopoeia

 Previous Next  Hide Timeline Show Change Symbols Show Change Details


Status: You are not viewing the legally effective version. This is the version as on 01/07/2020.

Amoxicillin Oral Suspension



General Notices

Action and use

Penicillin antibacterial.

DEFINITION

Amoxicillin Oral Suspension is a suspension of Amoxicillin Trihydrate in a suitable flavoured vehicle. It is prepared by dispersing the dry

ingredients in the specified volume of Water just before issue for use.

The dry ingredients comply with the requirements for Powders and Granules for Oral Solutions and Oral Suspensions stated under Oral

Liquids.

For the following tests prepare the Oral Suspension as directed on the label. The suspension, examined immediately after preparation
unless otherwise indicated, complies with the requirements stated under Oral Liquids and with the following requirements.

Content of amoxicillin, C16H19N3O5S

When freshly constituted not more than 120.0% of the stated amount. When stored at the temperature and for the period stated on the
label during which the Oral Suspension may be expected to be satisfactory for use, not less than 80.0% of the stated amount.

IDENTIFICATION

Carry out the method for thin-layer chromatography, Appendix III A, using the following solutions.

(1) Dilute a quantity of the oral suspension with sufficient sodium hydrogen carbonate solution to produce a solution containing the
equivalent of 0.25% w/v of amoxicillin.
(2) 0.25% w/v of amoxicillin trihydrate BPCRS in sodium hydrogen carbonate solution.
(3) 0.25% w/v of each of amoxicillin trihydrate BPCRS and ampicillin trihydrate BPCRS in sodium hydrogen carbonate solution.

CHROMATOGRAPHIC CONDITIONS

(a) Use a TLC silica gel silanised plate (Merck silanised silica gel 60 F254s (RP-18) plates are suitable).

(b) Use the mobile phase described below.

(c) Apply 1 µL of each solution.


(d) Develop the plate to 15 cm.
(e) After removal of the plate, allow it to dry in air, expose it to iodine vapour until spots appear and examine in daylight.

MOBILE PHASE
https://www.pharmacopoeia.com/bp-2020/formulated-specific/amoxicillin-oral-suspension.html?date=2020-07-01&text=amoxicillin+oral+suspension 1/3
2/9/2021 Amoxicillin Oral Suspension - British Pharmacopoeia

10 volumes of acetone and 90 volumes of a 15.4% w/v solution of ammonium acetate adjusted to pH 5.0 with glacial acetic acid.

SYSTEM SUITABILITY

The test is not valid unless the chromatogram obtained with solution (3) shows two clearly separated spots.

CONFIRMATION

The principal spot in the chromatogram obtained with solution (1) is similar in position, colour and size to that in the chromatogram obtained
with solution (2).

TESTS

Acidity or alkalinity

pH, 4.0 to 7.0, Appendix V L.

ASSAY

Carry out the method for liquid chromatography, Appendix III D, using the following solutions.

(1) Dilute a weighed quantity of the oral suspension containing the equivalent of 60 mg of amoxicillin with sufficient mobile phase A to

produce 100 mL, mix and filter (Whatman GF/C filter paper is suitable).
(2) 0.070% w/v of amoxicillin trihydrate BPCRS in mobile phase A.
(3) 0.0004% w/v of cefadroxil BPCRS and 0.003% w/v of amoxicillin trihydrate BPCRS in mobile phase A.

CHROMATOGRAPHIC CONDITIONS

(a) Use a stainless steel column (25 cm × 4.6 mm) packed with octadecylsilyl silica gel for chromatography (5 µm) (Hypersil 5 ODS is
suitable).
(b) Use isocratic elution and the mobile phase described below.
(c) Use a flow rate of 1 mL per minute.

(d) Use an ambient column temperature.


(e) Use a detection wavelength of 254 nm.
(f) Inject 50 µL of each solution.

MOBILE PHASE

8 volumes of mobile phase B and 92 volumes of mobile phase A.

Mobile phase A Mix 1 volume of acetonitrile and 99 volumes of a 25% v/v solution of 0.2M potassium dihydrogen orthophosphate adjusted

to pH 5.0 with 2M sodium hydroxide.

Mobile phase B Mix 20 volumes of acetonitrile and 80 volumes of a 25% v/v solution of 0.2M potassium dihydrogen orthophosphate

adjusted to pH 5.0 with 2M sodium hydroxide.

SYSTEM SUITABILITY

https://www.pharmacopoeia.com/bp-2020/formulated-specific/amoxicillin-oral-suspension.html?date=2020-07-01&text=amoxicillin+oral+suspension 2/3
2/9/2021 Amoxicillin Oral Suspension - British Pharmacopoeia

The Assay is not valid unless, in the chromatogram obtained with solution (3), the resolution factor between the peaks due to amoxicillin
and cefadroxil is at least 2.0. If necessary, adjust the composition of the mobile phase to achieve the required resolution.

DETERMINATION OF CONTENT

Determine the weight per mL of the oral suspension, Appendix V G, and calculate the content of C16H19N3O5S, weight in volume, using the

declared content of C16H19N3O5S in amoxicillin trihydrate BPCRS.

Repeat the procedure using a portion of the oral suspension that has been stored at the temperature and for the period stated on the label
during which it may be expected to be satisfactory for use.

STORAGE

The Oral Suspension should be kept at the temperature and used within the period stated on the label.

LABELLING

The quantity of active ingredient is stated in terms of the equivalent amount of amoxicillin.

 Previous Next 

© Crown Copyright 2019

Contact us Latest news Subscribe Back to the top

Terms and conditions Accessibility statement Privacy policy Cookie policy Sitemap

https://www.pharmacopoeia.com/bp-2020/formulated-specific/amoxicillin-oral-suspension.html?date=2020-07-01&text=amoxicillin+oral+suspension 3/3

You might also like